Frequencies for first 10,000 rows of dose_form variable in drug2015q2 dataset : Form of dose reported | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 6,204 62.04 62.04 CAPLET | 2 0.02 62.06 CAPSULE | 490 4.90 66.96 CAPSULE, HARD | 36 0.36 67.32 CAPSULES | 34 0.34 67.66 CHEWABLE TABLET | 2 0.02 67.68 COATED TABLET | 4 0.04 67.72 CONCENTRATE FOR SOLUTION FOR INFUSION | 19 0.19 67.91 CREAM | 6 0.06 67.97 CUTANEOUS PATCH | 1 0.01 67.98 CUTANEOUS SOLUTION | 3 0.03 68.01 DISPERSIBLE TABLET | 19 0.19 68.20 DROPS | 4 0.04 68.24 ENTERIC-COATED TABLET | 1 0.01 68.25 EYE DROPS | 1 0.01 68.26 EYE DROPS, SOLUTION | 5 0.05 68.31 FILM-COATED TABLET | 125 1.25 69.56 FORMULATION UNKNOWN | 121 1.21 70.77 GASTRO-RESISTANT CAPSULE, HARD | 1 0.01 70.78 GASTRO-RESISTANT TABLET | 1 0.01 70.79 GEL | 4 0.04 70.83 GELCAPS | 3 0.03 70.86 GRANULES | 2 0.02 70.88 INFUSION | 56 0.56 71.44 INHALATION | 5 0.05 71.49 INHALATION POWDER | 42 0.42 71.91 INHALATION POWDER, HARD CAPSULE | 3 0.03 71.94 INHALATION SOLUTION | 1 0.01 71.95 INHALER | 4 0.04 71.99 INJECTION | 151 1.51 73.50 INTRAUTERINE DELIVERY SYSTEM | 14 0.14 73.64 INTRAVENOUS INFUSION | 92 0.92 74.56 LIPOSOME INJECTION | 29 0.29 74.85 LIQUID | 1 0.01 74.86 LOTION | 1 0.01 74.87 LOZENGE | 1 0.01 74.88 LYOPHILIZED POWDER | 78 0.78 75.66 MATRIX PATCH | 61 0.61 76.27 MICROSPHERES | 2 0.02 76.29 MODIFIED RELEASE TABLET | 1 0.01 76.30 MODIFIED-RELEASE TABLET | 42 0.42 76.72 MOUTHWASH | 1 0.01 76.73 NASAL SPRAY | 12 0.12 76.85 NEBULISER SOLUTION | 1 0.01 76.86 NEBULISER SUSPENSION | 3 0.03 76.89 OINTMENT | 7 0.07 76.96 ORAL DROPS, SOLUTION | 2 0.02 76.98 ORAL DRUG UNSPECIFIED FORM | 4 0.04 77.02 ORAL POWDER | 2 0.02 77.04 ORAL SOLUTION | 3 0.03 77.07 ORAL SUSPENSION | 4 0.04 77.11 PATCH | 32 0.32 77.43 PER ORAL NOS | 3 0.03 77.46 POULTICE | 1 0.01 77.47 POULTICE OR PATCH | 1 0.01 77.48 POWDER | 5 0.05 77.53 POWDER AND SOLVENT FOR SOLUTION FOR I.. | 3 0.03 77.56 POWDER AND SOLVENT FOR SOLUTION FOR I.. | 20 0.20 77.76 POWDER FOR INFUSION | 4 0.04 77.80 POWDER FOR INJECTION | 4 0.04 77.84 POWDER FOR SOLUTION FOR INJECTION | 36 0.36 78.20 PROLONGED-RELEASE CAPSULE | 21 0.21 78.41 PROLONGED-RELEASE TABLET | 51 0.51 78.92 SLOW RELEASE CAPSULES | 3 0.03 78.95 SOL. AEROSOL METERED DOSE INH. | 1 0.01 78.96 SOLUTION | 20 0.20 79.16 SOLUTION FOR INFUSION | 94 0.94 80.10 SOLUTION FOR INJECTION | 190 1.90 82.00 SOLUTION FOR INJECTION IN PRE-FILLED .. | 26 0.26 82.26 SOLUTION FOR INJECTION IN PRE-FILLED .. | 75 0.75 83.01 SOLUTION FOR PERITONEAL DIALYSIS | 2 0.02 83.03 SPRAY (NOT INHALATION) | 1 0.01 83.04 SPRINKLE CAPSULES | 1 0.01 83.05 SUBLINGUAL TABLET | 1 0.01 83.06 SUPPOSITORY | 8 0.08 83.14 SUSPENSION | 8 0.08 83.22 SUSPENSION AND SOLUTION FOR SPRAY | 1 0.01 83.23 SUSTAINED RELEASE TABLETS | 3 0.03 83.26 SYRUP | 3 0.03 83.29 TABLET | 1,230 12.30 95.59 TABLETS | 136 1.36 96.95 TRANS-THERAPEUTIC-SYSTEM | 4 0.04 96.99 TRANSDERMAL PATCH | 10 0.10 97.09 UNK | 2 0.02 97.11 UNKNOWN | 61 0.61 97.72 UNKNOWN FORMULATION | 11 0.11 97.83 UNSPECIFIED | 213 2.13 99.96 VAGINAL RING | 2 0.02 99.98 VIAL | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 19 Apr 2017